Letters to the Editor

Therapeutic potential of β-lactam ceftriaxone for chronic pain in sickle cell disease

Departments of Pharmaceutical Sciences, Neurology and Rehabilitation, Bioengineering, Center for Biomolecular Sciences, and Sickle Cell Center, University of Illinois, Chicago, IL 60607
Departments of Pharmaceutical Sciences, Neurology and Rehabilitation, Bioengineering, Center for Biomolecular Sciences, and Sickle Cell Center, University of Illinois, Chicago, IL 60607
Departments of Pharmaceutical Sciences, Neurology and Rehabilitation, Bioengineering, Center for Biomolecular Sciences, and Sickle Cell Center, University of Illinois, Chicago, IL 60607
Haematologica Early view Oct 27, 2022 https://doi.org/10.3324/haematol.2022.281716